Danone (OTCMKTS:DANOY) Receives Average Rating of “Moderate Buy” from Brokerages

Danone (OTCMKTS:DANOYGet Free Report) has been assigned a consensus rating of “Moderate Buy” from the four research firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company.

A number of brokerages have recently weighed in on DANOY. Royal Bank Of Canada reiterated a “sector perform” rating on shares of Danone in a research report on Wednesday, October 29th. Morgan Stanley reaffirmed an “overweight” rating on shares of Danone in a research note on Friday, October 10th. Citigroup reiterated a “neutral” rating on shares of Danone in a report on Wednesday, October 29th. Finally, Jefferies Financial Group raised shares of Danone from an “underperform” rating to a “buy” rating in a research report on Tuesday, September 16th.

View Our Latest Analysis on DANOY

Danone Stock Up 1.0%

OTCMKTS DANOY opened at $17.92 on Friday. Danone has a 1 year low of $13.02 and a 1 year high of $18.63. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.95 and a quick ratio of 0.78. The business’s 50-day moving average is $17.96 and its 200 day moving average is $17.28.

Danone Company Profile

(Get Free Report)

Danone is a French multinational food-products company headquartered in Paris, with roots dating to 1919 when it was founded by Isaac Carasso. The company positions itself around nutrition and health-oriented food and beverage products, and it combines global brand management, manufacturing and distribution to serve a broad consumer base. Danone’s long history has been characterized by expansion beyond its original yogurt business into bottled water, infant and medical nutrition, and plant-based alternatives.

Danone’s principal activities include the development, production and marketing of dairy and plant-based products, bottled waters, and specialized nutrition for infants and medical patients.

Read More

Receive News & Ratings for Danone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danone and related companies with MarketBeat.com's FREE daily email newsletter.